InvestorsHub Logo
icon url

DewDiligence

06/22/21 5:27 PM

#1974 RE: DewDiligence #1971

Also, slide #24 in ENTA’s new slide set reveals new MoA and other info about EDP-721, the small-molecule HBV RNA destablizer that ENTA hopes will be the third drug in an all-oral functional cure.